Comparison of glucoheptonate single photon emission computed tomography and contrast-enhanced MRI in detection of recurrent glioma

Nuclear Medicine Communications

Volumn 32, Issue 3, 2011, Pages 206-211

  Santra, Amburanjan ^a   Sharma, Punit ^b   Kumar, Rakesh ^b   Bal, Chandrashekhar ^b   Kumar, Atin ^b   Julka, Pramod Kumar ^b   Malhotra, Arun ^b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

glioma; glucoheptonate; magnetic resonance imaging; recurrence; single photon emission computed tomography

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; GLUCEPTATE TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT CANCER; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; CHILD; CONTRAST MEDIA; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECURRENCE; SENSITIVITY AND SPECIFICITY; SUGAR ACIDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 79451475232     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328341c3e9     Document Type: Article

References (21)

1. Kingsley DPE, Kendall BE. CTof the adverse effects of therapeutic radiation of the central nervous system. Am J Neuroradiol 1981; 2: 453-460.
2. Van Dellen JR, Danziger A. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour. S Afr Med J 1978; 53:171-172.
3. Ostergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999; 90:300-305.
4. Ricci PE. Imaging of adult brain tumors. Neuroimaging Clin N Am 1999; 9:651-669.
5. Nelson SJ. Imaging of brain tumors after therapy. Neuroimaging Clin N Am 1999; 9:801-819.
6. Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, et al. Fluorine-1 8-FDGPET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 1997; 38:802-808.
7. Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996; 37:457-462.
8. Kim EE, Chung SK, Haynie TP, Kim G, Cho BJ, Podoloff DA, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 1992; 12:269-279.
9. Davis WK, Boyko OB, Hoffman JM, Hanson MW, Schold SC, Burger PC, et al. 18F-2-fluoro-2-deoxyglucose positron emission tomography correlation of gadolinium enhanced MR imaging of central nervous system neoplasia. Am J Neuroradiol 1993; 14:515-523.
10. Leveille J, Pison C, Karakand Y, Lemieux R, Betrand VJ. 99m glucoheptonate in brain-tumor detection: an important advance in radiotracer techniques. J Nucl Med 1977; 18:957-961.
11. Ziesman HA, O'Malley JP, Thrall JH. Nuclear medicine: the requisites in radiology. Elsevier Mosby 2006; 419-449.
12. Tanasescu DE, Wolfstein RS, Waxman AD. Critical evaluation of Tc-99m glucoheptonateas a brain scanning agent. J Nuci Med 1977; 18:630.
13. Barai S, Rajkamal, Bandopadhayaya GP, Pant GS, Haloi AK, Malhotra A, et al. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. Clin Neurosci 2005; 12:27-31.
14. Barai S, Bandopadhayaya GP, Julka PK, Naik KK, Haloi AK, Kumar R, et al. Role of Tc-glucoheptonic acid brain single photon emission computed tomography in differentiation of recurrent brain tumour and post-radiation gliosis. Australas Radiol 2004; 48:296-301.
15. Barai S, Bandopadhayaya GP, Julka PK, Malhotra A, Bal CS, Dhanpathi H. Imaging using Tc99m-tetrofosmin for the detection of the recurrence of brain tumour: a comparative study with Tc99m-glucoheptonate. J Postgrad Med 2004; 50:89-93.
16. Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comp Assist Tomogr 1987; 11:563-570.
17. Belohlavek Klener J, Vymazal J, Dbaly V, Tovarys F. The diagnostics of recurrent gliomas using FDG-PET: still questionable? Nucl Med Rev Cent East Eur 2002; 5:127-130.
18. Chen YR, Li WX, Lin YR, Chen LH. Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy. Ai Zheng 2004; 23:1210-1212.
19. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986; 158:149-155.
20. Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, et al. Positron emission tomography with O-(2-[18F] fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 2005; 57:505-511.
21. Valk PE, Dillon WP. Radiation injury of the brain. Am J Neuroradiol 1991; 12:45-62.